KATHERINE BECKER: Open Payments
NPI 1922457886 · LEBANON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 15 payments from 7 companies in 2025. Trend: 2023 $15 · 2024 $0 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Dexcom, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $28 |
| Exact Sciences Corporation | 1 | $19 |
| Amgen Inc. | 1 | $14 |
Products named: CAPLYTA, Ozempic, REXULTI, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, Rybelsus, UBRELVY, OTEZLA.
Industry payments across MO — which companies pay providers there.
